Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePlasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.AuthorsBos, M. K.; Lam, S. W.; Motta, G.; Helmijr, J. C. A.; Beaufort, C. M.; de Jonge, E.; Martens, J. W. M.; Boven, E.; Jansen, M. P. H. M.; Jager, A.; Sleijfer, S.PublicationBreast Cancer Research & Treatment, 2023, Vol 200, Issue 2, p271ISSN0167-6806Publication typeArticleDOI10.1007/s10549-023-06965-5